The Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bosco Armando Menezes & Emily Bosco Menezes
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bosco Armando Menezes and Emily Bosco Menezes, acting in concert and classified as non-promoters, have filed a revised disclosure under SEBI SAST Regulations for an open-market purchase of 15,000 shares of Hindustan Bio Sciences Ltd on 22 January 2026. The revision corrects an earlier error where the face value of shares was wrongly stated as Rs 10 instead of the actual Rs 2 (total equity share capital is Rs 2,05,01,600/- comprising 1,02,50,800 shares of Rs 2 each). After the acquisition, Bosco holds 2.63% (2,70,000 shares) and Emily holds 2.49% (2,55,000 shares), taking their combined holding from 4.98% to 5.12%, marginally crossing the 5% disclosure threshold. All other details in the original disclosure remain unchanged.
This is a minor, non-promoter open-market purchase and a clerical correction in the face value of shares. The acquisition is too small to materially affect the stock price or control of the company.